Laboratorios Farmacéuticos Rovi, S.A.

The future direction for Laboratorios Farmacéuticos Rovi, S.A. will depend largely on whether the Spanish drugmaker is tempted to sell its successful contract development and manufacturing organizat

The European Medicines Agency has recommended for EU-wide approval 13 new medicines, including two orphans - Global Blood Therapeutics ’ first-in-class therapy for sickle cell disease Oxbryta (voxelo

As Moderna, Inc. receives regulatory approvals in several countries, speculation has emerged about its plans to partner with an Indian company for the manufacture and/or marketing of its COVID-19 va

Laboratorios Farmaceuticos Rovi says it is weeks away from submitting its Doria once-a-month injectable formulation of risperidone via the European Union’s hybrid Article 10(3) pathway. A US filing f